Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anagenics ( (AU:AN1) ) has issued an announcement.
Anagenics Limited reported a significant improvement in operating cash flows for the quarter ended June 30, 2025, attributed to a successful business restructuring. The company’s Flouf Factor Growth Tonic has performed well, exceeding sales expectations and potentially generating higher royalties in FY2026. Anagenics is also in discussions with Roquefort Therapeutics regarding midkine antibody licensing. The company believes it has sufficient funds to support operations for the next two quarters without additional equity funding.
More about Anagenics
Anagenics Limited is a company operating in the haircare industry, focusing on products like the Bouf Haircare line. The company is exploring growth opportunities, including potential international market expansion, and is involved in discussions regarding midkine antibody licensing.
Current Market Cap: A$2.48M
For a thorough assessment of AN1 stock, go to TipRanks’ Stock Analysis page.